نتایج جستجو برای: knowledge based pharmaceutical companies

تعداد نتایج: 3404363  

Journal: :Anales del sistema sanitario de Navarra 2005
V Peralta

INTRODUCCIÓN Los médicos y la industria farmacéutica comparten el objetivo del progreso en el conocimiento científico; sin embargo, el principal interés del médico es proporcionar a sus pacientes el mejor tratamiento posible, mientras que el principal interés de la industria es vender su producto. La industria farmacéutica colabora en el desarrollo de importantes avances en medicina y tecnologí...

H. Olubunmi Aderemi, I. Ayodele Ojediran O. Olufunke Olasanmi S. Akinade Adegbite

This paper discussed the application of Information and Communication Technology (ICT) in pharmaceutical product marketing in Nigeria. Data for the study was obtained from 76 pharmaceutical firms in southwest Nigeria which comprised of about 95% of the pharmaceutical companies that were into manufacturing of drugs in Nigeria. The categories of firms surveyed include retail pharmacy, combination...

2010
Andries Brink

South Africa not infrequently hosts high-level cardiology meetings outside the auspices of South African professional medical societies and associations. Well-known cardiologists, particularly from the USA and Europe are invited to make presentations, which bring the best and most-recent advances in the field to this country. This is of course of great value to the selected group of delegates w...

Journal: :BMJ 2003
Richard Smith

One of my first experiences of the relation between medical journals and pharmaceutical companies occurred in the early 1980s after the BMJ had published papers suggesting that a new non-steroidal anti-inflammatory drug, benoxaprofen, might have serious side effects. We were visited by three stern men from Eli Lilly, the makers of the drug. Tony Smith, the deputy editor, conducted the meeting a...

2014
François Montastruc Guillaume Moulis Aurore Palmaro Virginie Gardette Geneviève Durrieu Jean-Louis Montastruc Dermot Cox

BACKGROUND The present study aimed to describe exposure and attitudes of French medical residents towards pharmaceutical industry. The study was performed shortly after the Mediator affair which revealed several serious conflicts of interest inside the French health system. METHODS AND FINDINGS A cross-sectional study was implemented among residents from 6 French medical faculties. Independen...

2010
Mouris Saghir Scott Stern

In the biotechnology industry today, there are many business models for project commercialization. These models range from independent vertical integration to certain forms of collaboration with pharmaceutical companies to complete acquisitions of projects by the big pharmaceutical companies. In this thesis, we wanted to study commercialization strategies of several biotechnology companies. We ...

Background: Today, one of the most important concerns in the pharmaceutical industry is achieving sustainability, and the pharmaceutical industry is recognized as a leading sector in corporate sustainability reporting. The purpose of this study was to identify, extract, prioritize and analyze the social factors and corporate characteristics which are effective in the sustainability reporting of...

Journal: :Sociology of health & illness 2008
John Abraham

A realist conceptualization of interests is proposed in opposition to the fashionable view that interests, objectivity and reality are merely social constructs, and that sociological analyses should be confined to discourse, actor-networks and micro-contextual practices. The objective interests of pharmaceutical companies in profit-maximization, and of patients/public health in the optimisation...

The Internet is changing the transaction pattern of B2B markets. One of the major concerns of IT knowledge-based companies is how to take advantage of B2B online markets. These companies believe that the only possible strategy for entering these markets is to launch independent websites, and they are usually reluctant to enter these markets due to the requirements such as financial resources an...

2010
Johanna Timonen Marina Bengtström Pekka Karttunen Riitta Ahonen

BACKGROUND Mandatory generic substitution (GS) was introduced in Finland on 1 April 2003. The aim of this study was to explore and compare the impacts of GS on the activities of pharmaceutical companies representing mainly original or generic pharmaceutical products in Finland. The self-reported impact of GS from pharmaceutical companies' perspective was explored with a focus on the number of e...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید